94714 ⎘
Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms; Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
COVALENT, CHEMOGENETIC ACTIVATORS FOR K2P POTASSIUM CHANNELS AND USES THEREOF
#2Compounds, Compositions and Methods
#3AZEPINE FUSED RING COMPOUND AS RIPK1 INHIBITOR AND USE THEREOF
#4SARM1 MODULATORS, PREPARATIONS, AND USES THEREOF
#5ANTICANCER COMPOUNDS
#63,4-Dihydroisoquinolin-1(2H)-Ones Derivatives as STING Antagonists and the Use Thereof
#7AMIDE COMPOUND AS POTASSIUM CHANNEL REGULATOR, AND PREPARATION THEREFOR AND USE THEREOF
#8AROMATIC RING-FUSED HETEROCYCLIC RING COMPOUND AS POTASSIUM CHANNEL REGULATOR, AND PREPARATION THEREFOR AND USE THEREOF
#9RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
#10Kinase Inhibitors and Uses Thereof
#11NMDA Receptor Antagonist and Use Thereof
#12Compounds, Compositions and Methods
#13COMPOUND AS PPAR AGONIST AND APPLICATION THEREOF
#14RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
#15BENZONITRIC HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF
#16INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION
#17PEPTIDOMIMETIC N5-METHYL-N2-(NONANOYL-L-LEUCYL)-L-GLUTAMINATE DERIVATIVES, TRIAZASPIRO[4.14]NONADECANE DERIVATIVES AND SIMILAR COMPOUNDS AS INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION
#18RIP1 inhibitory compounds and methods for making and using the same
#19Nrf2 REGULATORS
#20Compounds, Compositions and Methods
#21METHODS AND MATERIALS FOR INHIBITING NF-kB ACTIVITY
#22Anticancer compounds
#233-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#24P-phenylenediamine derivative as potassium channel regulator and preparation method and medical application thereof
#25AROMATIC RING OR HETEROAROMATIC RING DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF
#263-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#27Kinase inhibitors and uses thereof
#28RIP1 inhibitory compounds and methods for making and using the same
#29P-phenylenediamine derivative as potassium channel regulator and preparation method and medical application thereof
#30α,β-unsaturated amide compound
#31RIP1 inhibitory compounds and methods for making and using the same
#32RIP1 inhibitory compounds and methods for making and using the same
#333-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#343-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#353-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#36RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
#37RIP1 inhibitory compounds and methods for making and using the same
#38RIP1 inhibitory compounds and methods for making and using the same
#39RIP1 inhibitory compounds and methods for making and using the same
#40Therapeutic compounds and uses thereof
#41Methods for preparing fuel additives
#42Compound as PPAR agonist and application thereof
#43Compounds, Compositions and Methods
#44Kinase inhibitors and uses thereof
#45Nrf2 REGULATORS
#463-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#473-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#483-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#493-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#50RIP1 inhibitory compounds and methods for making and using the same
#51Thionyl tetrafluoride modified compounds and uses
#52Heterocyclic amides as kinase inhibitors
#53Nrf2 regulators
#54Heterocyclic amides as kinase inhibitors
#55Therapeutic compounds and uses thereof
#563-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#573-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#583-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#593-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#603-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#613-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#623-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#633-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#643-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#653-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#66Compounds, compositions and methods
#673-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#683-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#693-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#703-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#713-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#723-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#733-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#743-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#753-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#76Aryl and heteroaryl-fused tetrahydro-1,4-oxazepine amides as somatostatin receptor subtype 4 (SSTR4) agonists
#77Targeted notch pathway inhibitors
#78Nrf2 regulators
#79NRF2 regulators
#80Compounds, compositions and methods
#81HETEROCYCLIC AMIDES AS KINASE INHIBITORS
#82Compounds, compositions and methods
#83Crystalline forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide
#84CXCR7 receptor modulators
#85Therapeutic compounds and uses thereof
#86Compounds, compositions and methods
#87Heterocyclic amides as kinase inhibitors
#88Heterocyclic amides as kinase inhibitors
#89Fused heterocyclic compounds as ion channel modulators
#90PROCESSES FOR PREPARING FUSED HETEROCYCLIC ION CHANNEL MODULATORS
#91PROCESSES FOR PREPARING FUSED HETEROCYCLIC ION CHANNEL MODULATORS
#92Alkylene derivatives
#933-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#943-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#953-aryl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#963-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
#97Fused heterocyclic compounds as ion channel modulators
#98COMPOUNDS FOR USE IN SCREENING METHODS FOR SPINAL MUSCULAR ATROPHY
#99Substituted hetero-azepinones
#100Heterocyclic amides as kinase inhibitors
#101Fused heterocyclic compounds as ion channel modulators
#102PROCESSES FOR PREPARING FUSED HETEROCYCLIC ION CHANNEL MODULATORS
#103Histone deacetylase inhibitors and compositions and methods of use thereof
#104Fused heterocyclic compounds as ion channel modulators
#105STIMULATORS OF INCRETIN HORMONES SECRETION, METHOD FOR PREPARATION AND USE THEREOF
#106Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors
#107Benzyl sulfonamide derivatives as RORc modulators
#108Modulators of ATP-binding cassette transporters
#109Fused heterocyclic compounds as ion channel modulators
#110Fused heterocyclic compounds as ion channel modulators
#111Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
#112VASOPRESSIN V1A ANTAGONISTS
#113INHIBITORS OF HISTONE DEACETYLASE
#114Bicyclic sulfonamide derivatives which are L-CPT 1 inhibitors
#115Inhibitors of mTOR and Methods of Making and Using
#116Oxadiazole derivatives active on sphingosine-1-phosphate (S1P)
#117Amine derivative having NPY Y5 receptor antagonistic activity
#118COMPOUNDS
#119Compounds, Process for their Preparation, Intermediates, Pharmaceutical Compositions and their use in the Treatment of 5-HT6 Mediated Disorders such as Alzheimer's Disease, Cognitive Disorders, Cognitive Impairment Associated with Schizophrenia, Obesity and Parkinson's Disease
#120Lactams and uses thereof
#121NOVEL ANTI-ARRHYTHMIC AND HEART FAILURE DRUGS THAT TARGET THE LEAK IN THE RYANODINE RECEPTOR (RyR2)
#122Substituted Benzodiazepinones, Benzoxazepinones and Benzothiazepinones as Sodium Channel Blockers
#123Bicyclic sulfonamide derivatives which are L-CPT1 inhibitors
#124Compounds, Process for their Preparation, Intermediates, Pharmaceutical Compositions and their use in the Treatment of 5-HT6 Mediated Disorders such as Alzheimer's Disease, Cognitive Disorders, Cognitive Impairment Associated with Schizophrenia, Obesity and Parkinson's Disease
#125Benzoxazepine derivatives and use thereof
#126Amine derivative having NPY Y5 receptor antagonistic activity
#127Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same
#128Benzoxazine derivatives and uses thereof
#129Substituted amides
#130REMEDY FOR XANTHOMA
#131Derivatives of 2-alkoxy-3,4,5-trihydroxy-alkyl amides, preparation and use thereof, and compositions containing the same
#132CHEMICAL COMPOUNDS
#133Vasopressin Vantagonists
#134Novel Molecular Probes
#135Pharmaceutical Compositions Comprising Nitrogen-Containing Fused Ring Coumpounds
#136Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same
#137Benzoxazepine Compound
#138Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors
#139Substituted pyridyoxy amides
#140Benzoxazepine compounds, their production and use
#1417-aryl 1,5-dihydro-4,1-benzoxazepin-2(3H)-one derivatives and their use as progesterone receptor modulators
#142Agent for preventing or treating organ functional disorders and organ dysfunction
#143Skeletal muscle protecting agent
#1447-Aryl 1,5-Dihydro-4,1-Benzoxazepin-2(3H)-One Derivatives and Their Use As Progesterone Receptor Modulators
#145Novel Lactams And Uses Thereof
#146Production Method of Nitrogen-Containing Fused Ring Compounds
#147High-density lipoprotein-cholesterol level elevating agent
#148N-Acylated lipophilic amino acid derivatives
#149Highly Selective Novel Amidation Method
#150Bicyclic sulfonamide derivatives which are L-CPT1 inhibitors
#151Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
#152Benzoxazepine compounds, their production and use
#153Nitrogen-containing fused ring compounds and use thereof
#154Agent for preventing or treating organ functional disorders and organ dysfunction
#155Receptor agonists
#156Amide derivatives
#157Malonamide derivatives
#158Lactams and uses thereof
#159Skeletal muscle protecting agent
#160Benzoxazepine derivatives as selective estrogen receptor modulators
#161Substituted amides
#1627-aryl 1,5-dihydro-4,1-benzoxazepin-2(3)-one derivatives and their use as progesterone receptor modulators
#163Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)
#164Benzoxazine derivatives and uses thereof
#165N-acylated lipophilic amino acid derivatives
#166Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient